Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia | MicrobiomeTrials← Back to trialsNCT01660308
Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia
UNKNOWNOBSERVATIONAL
Trial Details
Start: 2011-06Est. Completion: 2016-08
Enrollment target: 40 participants Locations- National Taiwan University Hospital, Taipei, Taiwan, Taiwan
Other microbiome trials you might be interested in
Ewing SarcomaSolid TumorsRhabdoid TumorRhabdomyosarcomaNeuroblastomaMedulloblastomaDiffuse Intrinsic Pontine Glioma
A study to learn about safety and find out maximum tolerable dose of palbociclib given in combination with chemotherapy …
Birmingham, United StatesCompleted Aug 26, 2024
Metastatic Ovarian CarcinomaPeritoneal Carcinomatosis
Stage III Ovarian Cancer
Stage III Fallopian Tube Cancer
Metastatic Malignant Neoplasm in the Peritoneum
Stage IIb Ovarian Cancer
Stage IVa Ovarian Cancer
Stage IVa Fallopian Tube Cancer
Stage IIB Fallopian Tube Cancer
Women with history of tumor response insufficient to allow complete cytoreductive surgery after three cycles of previous…
Lille, FranceEst. completion Jun 2028
CancerNeoplasm
The study enrolled advanced cancer participants with unresectable or metastatic disease who were refractory to or were n…
Phoenix, United StatesCompleted Jul 2, 2025